Lobular carcinoma in situ (LCIS) is when there are abnormal cells in the lobules of the breast. The lobules are the part of the breast that produces milk. LCIS is not cancer. However, it can raise the risk of future breast cancer.
LCIS does not appear on imaging tests. It cannot be felt during a breast exam. It is usually found during a biopsy of other nearby breast tissue.
LCIS does not require treatment.
The doctor will monitor the breast for changes with:
- A physical and breast exam every 6 to 12 months
- A yearly mammogram
The risk of breast cancer may be reduced by:
- Reaching and keeping a healthy weight
- Regular physical activity
- Eating a healthful diet
- Avoiding alcohol or—or limiting it to 1 drink or less per day
American Cancer Society https://www.cancer.org
National Cancer Institute https://www.cancer.gov
LCIS—lobular carcinoma in situ. Breast Cancer website. Available at: http://www.breastcancer.org/symptoms/types/lcis. Accessed March 19, 2021.
Lobular carcinoma in situ. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/lobular-carcinoma-in-situ. Accessed March 19, 2021.
Lobular carcinoma in situ (LCIS). American Cancer Society website. Available at: https://www.cancer.org/cancer/breast-cancer/non-cancerous-breast-conditions/lobular-carcinoma-in-situ.html. Accessed March 19, 2021.
Wen HY, Brogi E. Lobular carcinoma in situ. Surg Pathol Clin. 2018;11(1):123-145.
- Reviewer: EBSCO Medical Review Board Mohei Abouzied, MD, FACP
- Review Date: 01/2021
- Update Date: 03/19/2021